WeVote
Log In

Bill

Bill

H 736

An act relating to medication adherence and continuity of care in inpatient health care settings

2025-2026 Regular Session Introduced by Sarita Austin and 11 co-sponsors

The bill aims to improve patient safety and care continuity in inpatient settings by mandating comprehensive medication reconciliation, patient education, and standardized discharg

Read first time and referred to the Committee on Health Care
0
WeVote Research Nonpartisan
Bill Summary · H 736

Bill Summary: H 736 (2025-2026) - Vermont

Purpose and intent

  • An act relating to medication adherence and continuity of care in inpatient health care settings.
  • The bill seeks to improve patient safety and quality of care by ensuring that medication-related processes in inpatient settings support adherence, proper transition of care, and continuity across providers and settings.

Key provisions and changes (as described in the bill text)

  • Medication adherence requirements: Establish standards or requirements to promote patient adherence to prescribed regimens during inpatient stays and at discharge, potentially including patient education, clear instruction, and follow-up plans.
  • Continuity of care: Provisions aimed at ensuring seamless transitions of care for patients moving between inpatient settings and outpatient or community-based care. This could involve standardized handoffs, medication reconciliation at key transition points, and coordinated discharge planning.
  • Medication reconciliation: Requirements for timely and accurate reconciliation of a patient’s medications upon admission, during stay, and at discharge to identify and resolve discrepancies.
  • Discharge planning and patient education: Mandates for comprehensive discharge instructions focused on medications, including dosage, timing, potential interactions, and what to do in case of adverse effects.
  • Accountability and quality measures: Possible implementation of performance metrics or reporting requirements related to medication management, adherence outcomes, and continuity of care, potentially tying to quality improvement initiatives.
  • Stakeholder coordination: Encouragement or mandates for coordination among inpatient facilities, primary care providers, pharmacists, and other care team members to support adherence and continuity.

Who is affected

  • Inpatient health care facilities and their staff (e.g., hospital units, acute care centers) responsible for medication management and discharge planning.
  • Pharmacists and pharmacy services involved in inpatient and discharge processes.
  • Healthcare providers responsible for prescribing, charting, educating, and coordinating patient care.
  • Patients receiving inpatient care, particularly those with complex medication regimens or transitions to outpatient care.

Procedural and timeline aspects

  • Status: Read first time; referred to the Committee on Health Care (as of 2026-01-21).
  • Next steps: The Health Care Committee would review, amend, and potentially advance the bill. If passed, it would move through the standard Vermont legislative process (committee votes, chamber readings, potential conference, and gubernatorial approval) with implementation timelines determined by enacted language (deadlines for compliance, phased rollouts, or effective dates).

Potential impact and considerations

  • Patient safety: By emphasizing reconciliation, education, and clear discharge plans, the bill aims to reduce medication errors and adverse drug events.
  • Care continuity: Strengthened handoffs between inpatient and outpatient care could reduce readmissions and improve adherence to treatment plans.
  • Operational changes: Hospitals and clinics may need to update policies, train staff, adopt standardized checklists, and possibly invest in information-sharing workflows and pharmacist involvement.
  • Measurement and accountability: If the bill includes metrics, facilities may be required to report adherence and transition-related outcomes, shaping quality improvement efforts.

Notes

  • The bill lists a broad group of co-sponsors, indicating bipartisan interest in medication safety and care continuity.
  • Specific numeric provisions (e.g., exact metrics, timelines for implementation) would be clarified in the final enacted text or committee amendments.

If you’d like, I can tailor this summary to emphasize particular provisions once the committee bill text is available or extract language from amendments as they’re released.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.